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Delayed-type hypersensitivity (DTH) 1 develops without adjuvant if the dose 
of SRBC  given is appropriate to the route of inoculation (1). Increasing the 
amount  of antigen  reduces  and  eventually abolishes  all  evidence of DTH. 
Animals blocked by an excessive dose of SRBC cannot be subsequently sensi- 
tized, even when an optimal dose of antigen is given subcutaneously, the most 
reliable route for inducing DTH in the mouse.  DTH does develop, however, 
when a massive intravenous dose of antigen is given to splenectomized mice, or 
mice that have received cyclophosphamide before immunization (2). The sup- 
pression of DTH cannot therefore be due to excess antigen, as such. The serum 
of DTH-suppressed mice will partially inhibit the induction and expression of 
DTH in normal recipients, an effect which is substantially increased by partial 
absorption of the serum with specific antigen (3). In contrast to a high dose of 
antigen (4), absorbed serum does not inhibit the proliferative response or the 
formation of plaque-forming cells (PFC)  in lymph nodes draining the site of 
antigen injection. Moreover, the specific antibody titer is increased by absorbed 
blocking serum even though the induction of DTH is totally suppressed by it. 
In light of indications that the products of the interaction between antigen 
and antibody depress the activated T cells which mediate DTH, and insofar as 
pretreatment with  specific  IGM  antibody has  been reported to  enhance the 
antibody response (5, 6), an important question arises concerning the functional 
relationship between the  mediators of DTH  and the T  cells responsible  for 
helper  activity  in  the  antibody  response.  Obviously,  a  successful  antibody 
response depends upon cooperation between the various cellular and humoral 
elements involved (7). It is possible that this can be accomplished efficiently 
only in certain sites,  and that the local enactment of a  DTH reaction is the 
process whereby the participating elements are assembled (8). After intrave- 
nous immunization, the spleen could be the locus of this coordinated series of 
events. Evidence in support of this concept is presented in the present report, 
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which deals with the site of blocking by immune  serum of the cells that mediate 
DTH to sheep erythrocytes  (SRBC) in mice. 
Materials  and  Methods 
Animals.  Except when cell transfers were made, the mice used were specific-pathogen-free 
mice of the outbred CD-1 strain (Charles River Breeding Laboratories, Inc., Wilmington, Mass.). 
Adoptive sensitization by spleen cell or lymph node cell transfer was performed syngeneically, 
using strains B6H-T~ F1 (C57B1/6 × CBA H-T6) or C57B1/6 mice from the breeding facilities of the 
Trudeau and Pasteur Institutes. Mice were used at 5 or 8 wk of age. 
Antigens.  SRBC were obtained from the same animal once weekly. Cells were collected and 
stored in Alsever's solution at 4°C. Chicken erythrocytes (CRBC) were obtained and stored in the 
same way. Cells were washed three times with normal saline and suspended to known density by 
hemocytometer count. 
Cyclophosphamide (CY).  CY was donated by Mead Johnson & Co.  (Evansville, Ind.) and by 
Lab.  Lucien  (Colombes,  France).  A  single dose  (200 mg/kg) was  given intravenously before 
immunization (2), though intraperitoneal or subcutaneous routes gave identical results. 
Immunization.  Except when  specified, 108 SRBC  were used for primary immunization by 
intravenous or by foot-pad inoculation. For modulation of the primary response, cyclophospha- 
mide was administered 2 days before intravenous immunization or concurrently with subcuta- 
neous immunization. 
Test for DTH.  DTH was measured after 24 h as the increase in foot-pad thickness elicited by 
an injection of 108 SRBC in a 40-~1 volume (1). 
Splenectomy.  Splenectomized mice were prepared 3 wk before an experiment by removing the 
spleen through a flank incision. The spleen was dissected from its pedicle and excised without 
attempting to prevent bleeding. The wound was closed by Mischel clips. 
Blocking Serum.  Serum containing specific inhibiters of activated T cells was prepared from 
mice  bled 4  days after intravenous  immunization with  10  ~ SRBC.  Its blocking activity was 
increased by partial absorption with packed SRBC  as previously described (3). Hereafter, 4-day 
serum and absorbed 4-day serum are referred to as $4 and AS4, respectively. 
Immune Cell Transfer.  Spleen cells for transfer to syngeneic recipients were prepared as in a 
previous study (9). The cells were pooled, washed twice, and enumerated in a hemocytometer. 
Viability, as assessed by dye exclusion with trypan blue, was not less than 90%. For the systemic 
cell transfer, mice received 0.5 ml of spleen cell suspension intravenously. Recipients were tested 
immediately for DTH by foot-pad injection of 108 SRBC. For the local transfer of DTH, the method 
of Metaxas and Metaxas-Biihler (10) was modified slightly; the specifically  sensitized lymphocytes 
and antigen were mixed and then introduced into the foot-pad of the normal or treated recipients. 
Results 
Adoptive Transfer of DTH by Spleen Cells from Anergic Mice.  Hypersensi- 
tivity to SRBC can be transferred  adoptively with isolated spleen cells from im- 
munized  donors. In the mouse,  the active cells bear the alloantigen  Thy-1  (11). 
Those mediating  specific sensitivity to SRBC perform well in normal recipients, 
where they survive with an apparent  half-life of about 45 days (12).  It has been 
observed,  however,  that  reactive  cells confer  no  DTH  upon  recipients  which 
have received 109 SRBC  4  days before cell transfer  (3).  Similarly, DTH  did not 
appear,  and  a  regional  antibody  response  did  not  develop  in  mice  given  an 
optimal  foot-pad  dose  of  SRBC  within  3  days  of  receiving  a  large  (109) 
intravenous  dose of SRBC  (1). On the other hand, serum of such mice, partially 
absorbed with SRBC,  blocked the induction and expression of DTH  (3), but did 
not inhibit the proliferative response or PFC production in the draining  node. It 
is evident,  therefore,  that  the effects of SRBC  and  AS4 on the production  and 
circulation of activated T  cells are significantly different. As a  first step towards 
explaining this difference, a  study was made of the capacity of spleen cells from ~5 
0 
P.  H.  LAGRANGE 
I 
AND  G.  B.  MACKANESS 
I 
• 
i  I  i  .  i  . 
237 
I 
4  6  8  10  14  20  28  35 
DAYS 
FIG.  1.  Local and systemic transfer of DTH with spleen cells from animals in which DTH 
was blocked by intravenous immunization with a  large dose of SRBC.  Donor mice were 
immunized intravenously with 109 SRBC on day 0. Representatives were tested for DTH at 
intervals during the next 35 days  (0). At each time point, one spleen equivalent of cells 
from similar mice was transferred to a  normal recipient.  Two groups of recipients were 
used: one received spleen cells by a systemic cell transfer (A), the other received a mixture 
of spleen cells and SRBC injected locally into the test foot-pad (A). The reactions elicited in 
the donors did not differ significantly at any time from those of the unimmunized controls, 
which were tested on day 4 only (hatched column). Mean of five mice -+ SEM. 
blocked mice to mediate  DTH by local and systemic transfer.  It was reasoned 
that local transfer would test the intrinsic capacity of donor T cells to mediate a 
DTH  reaction,  whereas  systemic  transfer  should  reveal,  in  addition,  their 
ability to reach the site of antigen deposition. 
Using this  approach,  the  kinetics  of the  blocking action of an  intravenous 
inoculum of l0  g SRBC was studied by adoptive transfer of spleen cells harvested 
at varying intervals after immunization.  The purpose of the experiment was to 
determine  whether  reactive  cells  are  produced  at  all,  or  whether  they  are 
produced and subsequently inhibited.  The results  (Fig.  1) show that  although 
the cell donors were completely anergic,  cell recipients  gave reactions  which 
were highly significant after both local and systemic transfer of cells harvested 
on days 8 and  10  (P  <  0.002).  The local transfer  was usually more effective, 
even though the number of cells transferred was less. The difference between 
the DTH reactions elicited in donors and recipients of locally transferred cells 
was  statistically  significant  (P  <  0.05)  at  all  times  through  day  14.  It  is 
concluded,  therefore,  that the mediators of DTH are present in the spleens of 
suppressed  mice.  It  is  apparent  that  they are  either  inhibited  in  situ  or are 
prevented from leaving the  spleen.  In either  case,  the evidence of a  previous 
experiment  suggests that the mechanism  involved is cyclophosphamide-sensi- 
tive  (2).  The  next  experiment  was  designed  to  examine  the  first  of these 
possibilities by testing the capacity of blocking serum to interfere with specifi- 
cally sensitized lymphocytes at the site of a local cell transfer. 
Absence of  a Direct Effect of  Blocking Serum on the Mediators of  DTH.  Since 
it has been reported that immune complexes can bind to activated T cells (13), 
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designed to test whether AS4 is adsorbed to activated T  cells,  thus rendering 
them functionally inactive, as suggested by Sinclair et al.  (17). 
Spleen  cell  suspensions  from  intravenously  immunized  mice  were washed 
twice in medium 199. The pellets of pooled spleen cells were resuspended in AS4 
or in normal  serum in the proportion of 1 ml of serum per spleen equivalent. 
The  suspensions  were incubated  for  1 h  at  37°C  in  a  humidified  atmosphere 
containing 5% CO2. The spleen cell preparations were then washed three times 
in medium containing 1% fetal calf serum at 4°C. The supernates after the first 
wash  were  kept  and  subsequently  tested  for  blocking  activity.  The  serum- 
treated  cells were  injected  intravenously  into  normal  recipients  which  were 
tested  immediately  for  DTH  by foot-pad  inoculation.  The  supernates  (post- 
absorption serum) were transferred into normal mice that had also received an 
aliquot of immune cells which had been treated with absorbed normal serum. 
Fig. 2 shows, as expected, that the blocking factors in AS4 inhibited DTH to 
SRBC (P <  0.001), and that blocking was specific since immune serum absorbed 
with  CRBC  did  not  block  the  reaction  in  SRBC-sensitized  mice  (P  =  0.4). 
Although not recorded in Fig. 2, the inverse was also true: AS4 (CRBC) blocked 
DTH to CRBC but not to SRBC. However, spleen cells incubated with homolo- 
gous blocking serum showed no change in viability and the specifically reactive 
component remained intact,  as shown by their undiminished capacity to confer 
DTH upon normal recipients.  Moreover, the supernate  (post-absorption serum) 
had not lost its T-cell inhibition  as a  result of absorption (P  <  0.005)  (Fig.  2). 
These results suggest that specifically sensitized lymphocytes are not inhibited, 
at least in vitro, by direct interaction with specific blocking factors in AS4. 
Indirect Effect of AS4 on the Mediators of DTH.  The preceding experiment 
did not exclude the possibility that union between AS4 and activated T cells is 
unstable,  and that treated cells could regain functional activity after transfer. 
This  would be less likely to happen  if AS4 were mixed with the  specifically 
sensitized cells and introduced directly into the test-site, as in the Metaxas and 
Metaxas-B~ihler  technique  for  transferring  DTH  (10).  This  possibility  was 
examined in groups of mice that were adoptively immunized by either systemic 
or local cell transfer. 
As  described  in  the  legend  of Fig.  3,  AS4  blocked  DTH only  when  given 
intravenously to recipients immunized by systemic cell transfer (P <  0.001);  it 
failed, almost completely, to prevent DTH when it was introduced locally with 
the  sensitizing  cells.  Conversely,  AS4 given  intravenously  did  not block the 
local  transfer  of DTH,  but did affect systemic transfer  to some extent  when 
given subcutaneously. This seems to say that there is a  geographic restriction 
to the blocking action of AS4.  It can be concluded,  in fact, that  AS4 actively 
blocks  DTH only when  AS4  is  present  in  the  systemic circulation  with  the 
specific mediators of DTH. 
It should be noted, too, that AS4 given intravenously did not interfere with 
the local transfer of DTH. This means that blocking serum does not affect the 
migratory  behaviour of the  accessory cells  (monocytes) which  are  necessary 
participants  in  a  DTH reaction.  This  appears  to  implicate  the  T  cell  as the 
victim of the blocking reaction. 
In an additional experiment,  SRBC and immune serum  ($4) were mixed as 
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FIG.  2.  Specificity  of blocking  and  absence  of direct  effect  of blocking  serum  on  the 
mediators of DTH.  Donor mice were immunized intravenously with 10  8 SRBC 2 days after 
treatment  with  CY.  5  days  later  the  spleens  from  these  sensitized mice  were  used  to 
prepare  cell  suspensions for immediate  transfer to  recipients,  or  for pretreatment with 
normal serum, or specific or nonspecific immune serum in vitro. Normal serum (NS), and 
the absorbed sera from  SRBC-immunized  (AS4-SRBC)  or  CRBC-immunized mice  (AS4- 
CRBC)  were  injected  intravenously  into  recipients of SRBC-sensitized cells.  The  DTH 
reactions elicited in the in vivo treated mice demonstrate a high degree of specificity in the 
blocking reaction. 
The aliquots of sensitized cells treated in vitro with NS, AS4-SRBC, or AS4-CRBC were 
centrifuged, and the supernates were used to test for blocking activity, while the cells were 
washed  and  tested  for  DTH  activity  by  adoptive  transfer.  The  reactions  elicited  in 
recipients of in vitro treated cells showed that the cells were functionally intact. Moreover, 
blocking activity of the supernatant serum was undiminished by absorption with immune 
spleen cells (supernate). Means of 5 -+ SEM. 
hypersensitive mice. The mixture elicited reactions greater than those produced 
with antigen alone, probably because the SRBC were more effectively retained 
at the inoculation site. The experiment showed again that mediator cells are not 
directly inhibited  by factors present  in blocking serum.  It was interesting  to 
find, however, that AS4 failed to elicit a DTH reaction even though it provoked 
a  PFC  response  in the  regional  node  (P.  H.  Lagrange,  unpublished  observa- 
tions). This suggests that free antigen is needed for eliciting a DTH reaction but 
not for the induction of an antibody response,  at least in hypersensitive mice. 
Localization of Site of  Action of  AS4.  We have shown that DTH develops in 
splenectomized mice even when blocking doses of antigen are administered (1). 
The same conditions prevail in animals given a dose of CY sufficient to prevent 
antibody formation.  Being the major organ of both antibody formation (18) and 
the  regulation  of some T-dependent  immune  responses  (19),  the  spleen  thus 
seemed a  likely anatomical  site for the event that results in blocking of DTH. 
This possibility was tested in a composite experiment in which blocking by AS4 240  SERUM  FACTORS  BLOCKING  DELAYED-TYPE  HYPERSENSITIVITY 
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FIG.  3.  In an experiment of design similar to that  of Fig.  2,  the blocking of DTH was 
shown to be geographically restricted to cells in the systemic circulation.  The sensitized 
donors  (D) and a  group of unimmunized controls  (C) were tested for DTH on day 5.  The 
remaining donors were used to prepare suspensions of normal or sensitized spleen cells for 
systemic or local transfer to normal recipients. The systemic recipients received one spleen 
equivalent of normal (C) or sensitized cells intravenously. Before testing for DTH, mice of 
separate groups were given 0.2 ml of normal serum  (NS) or AS4.  The former was given 
intravenously,  and the latter intravenously (iv) or subcutaneously  (sc) in the neck.  Even 
when administered  subcutaneously,  AS4 depressed  the foot-pad reaction in systemically 
sensitized mice.  With local transfer of sensitized cells, the effect was different.  Whether 
given intravenously or into the reaction site with spleen cells and antigen, AS4 caused no 
significant depression of DTH. Groups of 5 -+ SEM. 
was compared in normal,  splenectomized,  and CY-treated recipients of SRBC- 
sensitized spleen cells. 
The results of the experiment described in Fig. 4 show the reactivity to SRBC 
in the donor mice and in recipients given varying numbers of immune spleen 
cells intravenously. It can be seen that undiminished reactions were elicited in 
splenectomized or CY-treated  recipients  of l0  s immune  spleen  cells that  had 
been treated with normal  mouse serum.  However, in groups of similar recipi- 
ents that had received AS4 instead of normal mouse serum, significant blocking 
of DTH occurred only in normal recipients. The effect of AS4, which was almost 
abolished by splenectomy or CY alone,  was completely abolished  in  animals 
that were both splenectomized and treated with CY. It will be noted from Fig. 4 
that the dose of AS4 administered was enough to reduce the apparent level ofT- 
cell activity in normal recipients by a factor of 103. Thus, it seems that blocking 
factors in AS4 interfere with the function of the mediators of DTH through an 
event  occurring  in  the  spleen  and  involving  CY-sensitive  cells.  Trapping  of 
activated T cells in the spleen suggests itself as a likely mechanism. 
Discussion 
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FZG. 4.  Donor  mice  were  immunized  intravenously  with  5  x  107  SRBC  2  days  after 
treatment with CY.  On day 6,  representative donor mice were tested for DTH.  The rest 
were used to prepare spleen cell suspensions for transfer to various groups of normal or 
splenectomized  recipients.  An  additional  group  of 25  untreated  recipients  was  used  to 
obtain the  curve which shows  the relationship between the  intravenous dose  of spleen 
cells and  the level of DTH  conferred.  Half of the  remaining normal or  splenectomized 
recipients were given CY (200 mg/kg) 24 h before receiving the standard intravenous dose 
of l0  s viable nucleated spleen cells.  1 h  before cell transfer, the recipient mice were given 
0.2 ml of either normal mouse serum  (NS) or AS4 intravenously.  Immediately after cell 
transfer,  mice of all groups were tested for DTH by foot-pad inoculation with 108 SRBC. 
Splenectomy performed 3 wk earlier and CY given 24 h  beforehand were both effective in 
preventing the blocking action of AS4. Means of 5 mice -+ SEM. 
aider immunization with an  excessive dose of antigen cannot be  due to the 
absence of sensitized cells, because cell transfer showed that reactive cells were 
present in the spleens of anergic mice. It was then shown in several ways that 
the blocking factors which appear in serum do not interfere directly with the 
function of mediator cells.  In fact, blocking could be demonstrated only when 
blocking factors and reactive T  cells were present together in  the  systemic 
circulation. It must be emphasized, however, that this statement applies only to 
T  cells in a  recently activated state.  In effect, this means mitotically active 
cells, because it was demonstrated previously that only vinblastine-sensitive 
cells are susceptible to blocking by AS4 (13). 
The finding that  blocking factors are specific for homologously reactive T 
cells,  and can function only in the presence of an intact spleen,  implies that 
suppression of DTH is due to an immunologically specific event involving the 
spleen. The most likely role for the spleen in blocking DTH is that of selective 
trapping of mediator cells.  Experiments to demonstrate specific trapping of T 
cells have been reported (17, 20, 21), but they have relevance to the inductive 
phase of an immune response rather than to the mediators of DTH. The present 
experiments demonstrate quite clearly that the spleen has a part to play in the 
suppression of DTH which is observed after administration of large quantities 
of antigen. They also show that the underlying mechanism is ablated by prior 
treatment with cyclophosphamide. This  implies the participation of a  drug- 
sensitive population of cells. Four cell types deserve consideration. 
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phosphamide  depresses antibody production  preferentially when given before 
antigenic stimulation  (2, 22-26). It is likely, therefore, that after cyclophospha- 
mide the capacity to produce antibodies would have been depressed in animals 
that  had  been  adoptively  sensitized  with  SRBC-specific  T  cells  and  given 
blocking serum intravenously. Since blocking serum contains specific antibody, 
it is obvious that blocking is not due to antibody per se. Hence, by inference, the 
absence  of  blocking  in  CY-treated  animals  cannot  be  simply  due  to  the 
prevention  of antibody  production  by  the  transferred  cells.  This  makes  it 
difficult to directly implicate B cells in the blocking process. 
Monocyte Precursors.  The  monocyte  precursor  in  bone  marrow  is  radio- 
sensitive (27) and susceptible to cyclophosphamide (2, 28, 29).  It is well known 
that  monocytes are essential to the enactment  of a  DTH reaction  in the skin 
(30) or foot-pad (27).  It is conceivable, therefore, that the uptake of antigen by 
the spleen after intravenous immunization would serve to elicit the equivalent 
of a  DTH  reaction  in  that  organ,  with  a  resulting  retention  of specifically 
reactive lymphocytes and  an  accompanying accumulation of monocytes. Such 
an  event  would  obviously limit  the  availability  of cells  in  circulation  for  a 
reaction  in the  foot-pad,  for example.  It was observed,  however, that  a  local 
transfer of DTH was possible in systemically blocked mice (Fig.  3). Obviously, 
retention of monocytes by the spleen cannot explain the blocking phenomenon. 
Suppressor  Cells.  There is substantial evidence for the existence of suppres- 
sor T  cells. They are usually detected through their capacity to interfere with 
antibody  production  (31).  It  has been  shown  more recently,  however,  that  T 
cells with a  capacity to suppress cell-mediated hypersensitivity also appear in 
the spleen under the conditions that lead to suppression of DTH (32). Therefore, 
it must be admitted that a  suppressor cell, which is sensitive to cyclophospha- 
mide, could be involved in the blocking of DTH (33).  If so, it must be assumed 
that blocking factors actually induce the formation of the suppressor cells and 
that  the  inductive  process  is  very  rapid  because  blocking  is  complete  and 
instantaneous  in  adoptively sensitized  animals.  Moreover,  it  can be deduced 
from the present experiments that a suppressor cell, if it exists, is not available 
in the circulation to exert its suppressive effect on a  DTH reaction elicited in 
the  foot-pad.  The  results  of  experiments  designed  to  evaluate  the  role  of 
suppressor cells in the blocking of DTH will be reported in a subsequent paper. 
Dendritic  Cells.  The  dendritic  cell,  which  has  a  known  capacity  to  trap 
antigen-antibody complexes at the cell surface (34), is very sensitive to radiation 
(35).  It  might  therefore  be  sensitive  to  a  radiomimetic  drug  such  as  CY, 
although no evidence for this has been reported. Since a low intravenous dose of 
SRBC (105-106) causes T-cell activation and DTH without causing antibodies to 
be formed (including an absence of PFC), whereas larger doses cause antibody 
production without DTH even though the activated T  cells are present in the 
spleen (Fig. 1), it seems plausible that the association between activated T cells 
and antibody-forming B cells may be more than circumstantial: it may represent 
a true physical relationship which could involve the dendritic macrophage as a 
focus for the cellular cooperation that results in antibody production. It may be, 
in fact, that the germinal center is a morphological structure created to satisfy 
the necessity for cooperation between cell types. According to this hypothesis, 
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become  associated  with  dendritic  macrophages,  thus  creating  the  attractive 
focus that prevents the release of activated T cells from the spleens of massively 
immunized  mice,  or causes them  to  become trapped  in  that  organ  after the 
passive  administration  of AS4  to  adoptively  sensitized  subjects.  If  such  a 
mechanism  exists,  the  molecular  mechanism  and  the  relevant  receptors  in- 
volved in cell-cell binding have yet to be elucidated. 
There is a long history to the close functional relationship that seems to exist 
between the phenomenon of DTH and the mechanism of antibody formation (8, 
36). It has been suggested, in fact, that when a  DTH reaction is observed in the 
spleen  it  is  a  displaced  expression  of a  physiological  process  that  normally 
occurs in lymphoid tissue during the inductive phase of an antibody response. 
Viewed in this way, the blocking of DTH in animals  immunized  with a  large 
intravenous dose of antigen cannot be thought of as suppression of a particular 
form of immunological reactivity, but rather as the redirection of cells (37) from 
one possible role as the mediators of DTH to an alternative role as helper cells 
in antibody formation. This, however, may be far too simplistic an explanation 
for the observed effects of serum factors on the expression of DTH in mice. It is 
consistent,  however,  with  the  frequent  coexistence  of  specific  anergy  and 
hypergammaglobulinemia. 
Summary 
When mice have been rendered anergic by a  large intravenous dose of sheep 
erythrocytes,  their  inability  to mount  a  delayed-type hypersensitivity  (DTH) 
reaction is not due to an absence of mediator cells, for these can be detected in 
the  spleen  by cell  transfer.  Nor  is  it  due to disappearance  of accessory cells 
(monocytes)  from  circulation.  The  serum  of anergic  mice  contains  blocking 
factors which are more abundant  after absorption  with antigen.  Such factors 
are unable to inactivate the mediators of DTH in vitro, nor do they suppress a 
DTH reaction when introduced locally into the reaction site. They are active, 
however,  when given  intravenously  to systemically sensitized  mice,  provided 
that the sensitized animal has an intact spleen. If the spleen has been removed 
or the recipients of sensitized  cells have been treated with cyclophosphamide 
before cell  transfer,  blocking  factors  are  no  longer  able  to  suppress  a  DTH 
reaction.  Reasons are given for the belief that suppression of DTH in animals 
undergoing a vigorous antibody response is due to the diversion of reactive cells 
from circulation to undertake an alternative  role in antibody formation in the 
spleen. 
Received for publication 29 March 1978. 
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